Demand for algae in animal feed industry and advancements in algaculture technologies is expected to drive the Global Algaculture Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Algaculture Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Algaculture Market is anticipated to grow with a CAGR of 6.23% in the forecast period, 2024-2028. The Global Algaculture Market is primarily driven by several key factors. First, the increasing demand for algae in the production of biofuels and the rising awareness of its health benefits are significant drivers. Second, the growing utilization of algae in wastewater treatment due to its absorbent properties also enhances market growth.’ Technological advancements in algae harvesting, coupled with the rising interest in alternative protein sources, further propel the market growth.
The global algaculture market, which refers to the farming of algae, is experiencing a significant surge in growth. Algae, known for its high versatility and sustainability, finds applications in numerous industries, including food and beverages, pharmaceuticals, biofuels, cosmetics, and more. Its unique properties, such as its ability to efficiently convert sunlight and carbon dioxide into biofuels through photosynthesis, make it a valuable resource in addressing various environmental challenges. In the food and beverage industry, algae is being explored as a nutritious and sustainable ingredient.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Algaculture Market.”
https://www.techsciresearch.com/report/algaculture-market/8234.html
With its rich nutritional profile, including high protein content and essential fatty acids, algae-based products offer a promising alternative to traditional food sources. Moreover, the cultivation of algae requires significantly less land and water compared to conventional agriculture, making it a more sustainable option. This not only provides an opportunity for new and innovative food products but also contributes to a greener and more sustainable food system.
In the pharmaceutical field, researchers are investigating the potential of algae-derived compounds for the development of new drugs and therapies. Algae contain a wide range of bioactive compounds, including antioxidants and anti-inflammatory agents, which have shown promising results in various studies. This opens up new avenues for the discovery of novel treatments and the improvement of existing ones, leading to advancements in healthcare and better patient outcomes.
Biofuels derived from algae are gaining attention as a renewable and sustainable energy source. Algae can efficiently convert sunlight and carbon dioxide into biofuels, such as biodiesel and bioethanol, through the process of photosynthesis. This renewable energy solution has the potential to reduce greenhouse gas emissions and dependence on fossil fuels, contributing to a greener and more sustainable future. Additionally, ongoing research and development in the field of algal biofuels are focused on improving the efficiency and scalability of production processes, making it a viable and economically feasible energy solution.
Furthermore, the applications of algae extend beyond traditional industries. Advances in biotechnology have enabled the exploration of algae's potential in wastewater treatment, where it can help remove pollutants and purify water. Algae's natural ability to absorb nutrients and contaminants makes it an effective tool in water remediation efforts. Additionally, algae can play a role in carbon capture and sequestration, helping to mitigate the effects of climate change by absorbing carbon dioxide from the atmosphere. By harnessing the power of algae, we can create a more sustainable and balanced ecosystem.
Moreover, researchers are investigating the use of algae in the production of biodegradable plastics, offering a sustainable alternative to traditional plastic materials. Algae-based bioplastics have the potential to reduce the environmental impact of plastic waste, as they can degrade naturally without causing harm to the environment. This innovation holds promise for a more circular economy and a reduction in plastic pollution. With increasing environmental concerns and a growing emphasis on sustainable practices, there is a rising demand for algae products worldwide. The continuous advancements in biotechnology and the exploration of algae's unique properties are unlocking new possibilities for innovative uses. As the market expands, algae emerge as a key player in the pursuit of a greener and more sustainable future, with its potential to revolutionize various industries and contribute to a more harmonious relationship between humans and the environment. The Global Algaculture Market is segmented into type of algae, technique, application, regional distribution, and company.
Based on type of algae, Microalgae is dominating the global algaculture market thanks to its remarkable characteristics. With its easy and rapid growth, microalgae thrives in diverse environments, making it a highly adaptable organism. Not only that, but it is also exceptionally rich in proteins, omega-3 fatty acids, and antioxidants, making it a valuable resource for various industries. Microalgae serves as a sustainable, high-yield biomass, catering to industries ranging from food and feed to cosmetics, pharmaceuticals, and biofuels. Its versatility and nutritional profile make it an attractive ingredient for the food industry, while its potential for producing biofuels offers a sustainable alternative to fossil fuels. Moreover, microalgae plays a crucial role in environmental conservation. Its ability to capture carbon dioxide from the atmosphere makes it a promising solution for mitigating greenhouse gas emissions.
Additionally, microalgae shows significant potential in wastewater treatment, helping to purify water resources and promote environmental sustainability. With its multi-sectoral utility and environmental benefits, microalgae stands as a frontrunner in the global algaculture market, offering a sustainable and versatile solution for various industries while contributing to the preservation of our planet.
Based on region, The Asia Pacific region is currently dominating the Global Algaculture Market primarily due to its strategic geographical location and favorable climatic conditions. The region is surrounded by several water bodies, which provide an ideal environment for algae production. Furthermore, the high population density in this region offers an enormous consumer base for algal products, ranging from food to cosmetics and pharmaceuticals. Additionally, the region boasts of support from the government in terms of policies and subsidies that encourage the growth of the algaculture industry. Technological advancements and increased investment in research and development in these countries have also contributed to Asia Pacific's dominance in the Global Algaculture Market.
Major companies operating in Global Algaculture Market are:
- Marigan Holding B.V.
- Prolgae Spirulina Supplies Pvt. Ltd.
- Swedish Algae Factory Ab
- Monzon Biotech S.L.
- Algatech Ltd.
Download Free Sample Report:
https://www.techsciresearch.com/sample-report.aspx?cid=8234
Customers can also request for 10% free customization on this report.
“The future of the global algaculture market looks highly promising, fueled by the rapidly growing demand for algae products in various industries, including food and beverage, pharmaceutical, and cosmetic. This surge in demand can be attributed to the remarkable nutritional value and natural properties of algae. Moreover, the continuous advancements in biotechnology and genetic engineering are expected to play a pivotal role in driving the production of algae, thus further propelling the growth of the market. Furthermore, the increasing awareness about the numerous environmental benefits associated with algae cultivation is anticipated to significantly boost the adoption of algaculture.
Algae not only have the potential to sequester carbon, but they also contribute to effective wastewater treatment. These eco-friendly aspects highlight the immense potential of algaculture as a sustainable and environmentally conscious industry. Considering these factors, the algaculture market is poised for substantial growth in the foreseeable future, offering exciting opportunities for businesses and investors alike.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.
“Algaculture Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type of Algae (Microalgae and Macroalgae), By Technique (Monoculture, Mixed Culture, Serial Dilution, Others), By Application (Fertilizers, Feed, Food Colouring, Pharmaceuticals, Others), By Region and Competition”, has evaluated the future growth potential of Global Algaculture Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Algaculture Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
This report studies the global market size of Robotic Surgery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Robotic Surgery Systems in these regions.
This report also studies the global Robotic Surgery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Market size by End User
Rest of Central & South America
The study objectives of this report are:
To study and analyze the global Robotic Surgery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
The latest market intelligence study on the Immunohistochemistry market brings in the best of both qualitative and quantitative assessment techniques to explore the market size, share, and status of the Immunohistochemistry market for the forecast period, 2019 - 2026.
The extensive examination of the global business environment provides a detailed analysis of the key driving forces and challenges with the aim to give the stakeholders, business owners, and filed marketing executives a competitive advantage over others.
The study further probes into prominent challenges, technology advancements, current trends and lucrative avenues often considered as the boosting elements for the Immunohistochemistry market for the forecast period, 2013 - 2018.The top manufacturers covered in this reportAbcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies.
It is used for cancer diagnosis, because it determines the presence of tumor antigens.
It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label.
Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells.Download Free Sample PDF Copy of this Report@ https://www.reportsanddata.com/sample-enquiry-form/2198Type (Revenue, USD Million; 2016–2026)AntibodiesPrimary AntibodiesSecondary AntibodiesEquipmentSlide Staining SystemsTissue MicroarraysTissue Processing SystemsSlide ScannersOthersReagentsHistological StainsBlocking Sera and ReagentsChromogenic SubstratesFixation ReagentsStabilizersOrganic SolventsProteolytic EnzymesDiluentsKitsApplication (Revenue, USD Million; 2016–2026)DiagnosticsCancerInfectious DiseasesCardiovascular DiseasesAutoimmune DiseasesDiabetes MellitusNephrological DiseasesDrug TestingEnd Use (Revenue, USD Million; 2016–2026)Hospitals and Diagnostic LaboratoriesClinicsResearch InstitutesOthersDealing with the competition and competitorsThe subject matter experts conducting the study offer a deep understanding of how prominent leaders have managed to navigate the potential buyers and competitive dynamics influencing their brand positioning in the industry The Immunohistochemistry market analysis provides everything a business owner needs in order to succeed.Here are the questions we answer...What are the future opportunities in store for the vendors operating in the Immunohistochemistry market?What does the competitive landscape look like?Which emerging technologies are believed to impact the Immunohistochemistry market performance?What are the key trends and dynamics?Which regulations that will impact the industry?Which segment will offer the most opportunity for growth between 2019 and 2026?Where will most developments take place in the long term?Who are the most prominent vendors and how much market share do they occupy?What are the latest technologies or discoveries influencing the Immunohistochemistry market growth worldwide?We can also provide the customized separate regional or country-level reports, for the following regions:North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & AfricaHelping you establish a strong foothold in the industryThe Immunohistochemistry report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services.
